THOMAS SPERANGER: Open Payments
NPI 1154840080 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 14 payments from 7 companies in 2025. Trend: 2023 $338 · 2024 $243 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $135 |
| Exact Sciences Corporation | 3 | $56 |
| ABBVIE INC. | 2 | $42 |
| Bausch Health US, LLC | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Wegovy, Cologuard Collection Kit, QULIPTA, Ozempic, VRAYLAR, WELLBUTRIN, PREVNAR 20, EVENITY.
Industry payments across PA — which companies pay providers there.
